Patent Assignment
Reel/Frame 061625/0493
Corrective Assignment to Correct the Nature of Conveyance Should Be Merger with an Effective Date of 07/07/2022 Previously Recorded at Reel: 061123 Frame: 0841. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2022-10-07
Pages: 9
Assignor
COMET THERAPEUTICS, INC.
Executed: 2022-07-07
Assignee
VECTIVBIO COMET AG
AESCHENVORSTADT 36, BASEL, 4051, SWITZERLAND
Covered Property
(1)
Pantethenoylcysteine Derivatives and Uses Thereof
Application:
17/598,569 →
Publication:
US 2023/0093594
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 29, 2022
From: COMET THERAPEUTICS, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 059420/0866 →
Assignment of Assignor's Interest
Sep 16, 2022
From: TAVERAS, ARTHUR GEORGE; KUSCER, ENEJ; SEKIRNIK, ANGELINA ROBERTA
To: COMET THERAPEUTICS, INC.
Reel/Frame 061123/0768 →
Change of Name
Sep 16, 2022
From: COMET THERAPEUTICS, INC.
To: VECTIVBIO COMET AG
Reel/Frame 061123/0841 →
Release of Security Interest
Aug 24, 2023
From: KREOS CAPITAL VI (UK) LIMITED
To: VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC.
Reel/Frame 064702/0362 →